BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 6805948)

  • 1. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathway.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Carcinogenesis; 1982; 3(12):1411-4. PubMed ID: 6817941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of teleocidin-caused epidermal ornithine decarboxylase induction by phospholipase A2-, cyclooxygenase- and lipoxygenase-inhibitors.
    Nakadate T; Aizu E; Yamamoto S; Fujiki H; Sugimura T; Kato R
    Jpn J Pharmacol; 1985 Mar; 37(3):253-8. PubMed ID: 3923244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors controlling tumor promotion induced by TPA].
    Kato R; Yamamoto S; Nakadate T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):782-9. PubMed ID: 3083783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potent anti-tumor-promoting agent isoliquiritigenin.
    Yamamoto S; Aizu E; Jiang H; Nakadate T; Kiyoto I; Wang JC; Kato R
    Carcinogenesis; 1991 Feb; 12(2):317-23. PubMed ID: 1899810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Gan; 1984 Mar; 75(3):214-22. PubMed ID: 6427052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor.
    Nakadate T; Yamamoto S; Iseki H; Sonoda S; Takemura S; Ura A; Hosoda Y; Kato R
    Gan; 1982 Dec; 73(6):841-3. PubMed ID: 6819174
    [No Abstract]   [Full Text] [Related]  

  • 8. Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: a comparison between SENCAR and NMRI mice.
    Fischer SM; Fürstenberger G; Marks F; Slaga TJ
    Cancer Res; 1987 Jun; 47(12):3174-9. PubMed ID: 3107806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lipoxygenase and cyclooxygenase inhibitors on the induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate and isoproterenol in mouse tissues in vivo.
    Uzumaki H; Yamamoto S; Kato R
    Carcinogenesis; 1986 Feb; 7(2):289-94. PubMed ID: 3081271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Jpn J Pharmacol; 1985 Jun; 38(2):161-8. PubMed ID: 3928951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Pong RC; Erickson D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polycyclic aromatic compounds and phorbol esters on ornithine decarboxylase and aryl hydrocarbon hydroxylase activities in mouse liver.
    Raunio H; Pelkonen O
    Cancer Res; 1983 Feb; 43(2):782-6. PubMed ID: 6848192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate.
    Huang MT; Smart RC; Wong CQ; Conney AH
    Cancer Res; 1988 Nov; 48(21):5941-6. PubMed ID: 3139287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate in isolated epidermal cells is inhibited by lipoxygenase inhibitors but not by cyclooxygenase inhibitors.
    Yamamoto S; Sasakawa N; Kiyoto I; Nakadate T; Kato R
    Eur J Pharmacol; 1987 Nov; 144(1):101-3. PubMed ID: 3125055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis.
    Jiang H; Yamamoto S; Kato R
    Carcinogenesis; 1992 Mar; 13(3):355-9. PubMed ID: 1547524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate.
    Kozumbo WJ; Seed JL; Kensler TW
    Cancer Res; 1983 Jun; 43(6):2555-9. PubMed ID: 6850576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by epidermal extracts of the 12-O-tetradecanoylphorbol-13-acetate induced peak of ornithine decarboxylase activity in the mouse epidermis.
    Astrup EG
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 35(3):229-37. PubMed ID: 6116315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonate stimulates prolactin release in vitro: a role for the fatty acid and its metabolites as intracellular regulator(s) in mammotrophs.
    Canonico PL; Judd AM; Koike K; Valdenegro CA; MacLeod RM
    Endocrinology; 1985 Jan; 116(1):218-25. PubMed ID: 2981065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.